EAM
Exome Asset Management Portfolio holdings
AUM
$110M
This Quarter Return
+0.6%
1 Year Return
+24.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
+$112M
(-3.8%)
Cap. Flow
-$7.72M
Cap. Flow
% of AUM
-6.87%
Top 10 Holdings %
Top 10 Hldgs %
40.26%
Holding
80
New
27
Increased
6
Reduced
11
Closed
28
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$5.2M |
| 2 |
Amgen
AMGN
|
$3.69M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$2.94M |
| 4 |
AUTL
Autolus Therapeutics
AUTL
|
$2.92M |
| 5 |
Disc Medicine
IRON
|
$2.75M |
Top Sells
| 1 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$4.64M |
| 2 |
Dr. Reddy's Laboratories
RDY
|
$3.79M |
| 3 |
Avidity Biosciences
RNA
|
$3.45M |
| 4 |
Celldex Therapeutics
CLDX
|
$2.98M |
| 5 |
Geron
GERN
|
$2.93M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Natera
NTRA
$23B
| $2.02M | 1.8% |
18,650
| – | – |
|
27
Biohaven
BHVN
$1.71B
| $2.01M | 1.79% |
+57,800
| New | +$2.01M |
|
28
BridgeBio Pharma
BBIO
$9.91B
| $2M | 1.78% |
78,907
+30,100
| +62% | +$762K |
|
29
Fulcrum Therapeutics
FULC
$353M
| $1.88M | 1.67% |
+302,700
| New | +$1.88M |
|
30
Apellis Pharmaceuticals
APLS
$3.51B
| $1.8M | 1.6% |
+46,900
| New | +$1.8M |
|
31
Alphatec Holdings
ATEC
$2.35B
| $1.69M | 1.51% |
+162,100
| New | +$1.69M |
|
32
AbCellera Biologics
ABCL
$1.19B
| $1.52M | 1.36% |
+514,900
| New | +$1.52M |
|
33
Zai Lab
ZLAB
$3.48B
| $1.5M | 1.34% |
86,700
+21,400
| +33% | +$371K |
|
34
Pliant Therapeutics
PLRX
$105M
| $1.33M | 1.19% |
+124,000
| New | +$1.33M |
|
35
Rezolute
RZLT
$630M
| $1.21M | 1.08% |
+282,400
| New | +$1.21M |
|
36
Alvotech
ALVO
$2.48B
| $1.2M | 1.07% |
+99,000
| New | +$1.2M |
|
37
Gossamer Bio
GOSS
$587M
| $1.02M | 0.9% |
+1,127,699
| New | +$1.02M |
|
|
ELEV
38
DELISTED
Elevation Oncology
ELEV
| $997K | 0.89% |
369,322
| – | – |
|
39
Establishment Labs
ESTA
$1.11B
| $986K | 0.88% |
+21,700
| New | +$986K |
|
|
SYRS
40
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $821K | 0.73% |
+159,175
| New | +$821K |
|
41
Quanterix
QTRX
$202M
| $788K | 0.7% |
59,650
| – | – |
|
42
Q32 Bio
QTTB
$20.9M
| $787K | 0.7% |
43,865
-21,156
| -33% | -$380K |
|
43
VYNE Therapeutics
VYNE
$8.09M
| $696K | 0.62% |
353,434
-62,000
| -15% | -$122K |
|
44
PMV Pharmaceuticals
PMVP
$82.1M
| $581K | 0.52% |
+358,400
| New | +$581K |
|
45
Aprea Therapeutics
APRE
$8.91M
| $558K | 0.5% |
+137,174
| New | +$558K |
|
|
TECX
46
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $533K | 0.47% |
32,389
-28,746
| -47% | +$450K |
|
|
ADAG
47
Adagene
ADAG
$103M
| $462K | 0.41% |
150,876
-4,507
| -3% | -$13.8K |
|
|
IMAB
48
I-MAB
IMAB
$380M
| $453K | 0.4% |
271,400
-54,362
| -17% | -$90.8K |
|
|
PROC
49
DELISTED
Procaps Group, S.A. Ordinary Shares
PROC
| $321K | 0.29% |
+126,901
| New | +$321K |
|
50
HilleVax
HLVX
$105M
| $260K | 0.23% |
+18,000
| New | +$260K |
|